<TABLE> <S> <C>

<ARTICLE>                     5
<CIK>                         0001053369
<NAME>                        ELITE PHARMACEUTICALS
<MULTIPLIER>                                   1
<CURRENCY>                                     DOLLAR

<S>                                             <C>
<PERIOD-TYPE>                                  3-MOS
<FISCAL-YEAR-END>                              MAR-31-2000
<PERIOD-START>                                 APR-01-2000
<PERIOD-END>                                   JUN-30-2000
<EXCHANGE-RATE>                                1
<CASH>                                         3,586,558
<SECURITIES>                                   0
<RECEIVABLES>                                  0
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               4,008,543
<PP&E>                                         3,021,542
<DEPRECIATION>                                   450,056
<TOTAL-ASSETS>                                 8,411,586
<CURRENT-LIABILITIES>                            313,095
<BONDS>                                        2,885,000
                          0
                                    0
<COMMON>                                       89,088
<OTHER-SE>                                     5,124,403
<TOTAL-LIABILITY-AND-EQUITY>                   8,411,586
<SALES>                                        0
<TOTAL-REVENUES>                               0
<CGS>                                          0
<TOTAL-COSTS>                                  591,004
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             58,125
<INCOME-PRETAX>                               (589,016)
<INCOME-TAX>                                   555
<INCOME-CONTINUING>                           (589,571)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                  (589,571)
<EPS-BASIC>                                   (.07)
<EPS-DILUTED>                                 (.07)


</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission